Loading
Latest filing published 03 Mar 2023 for Axcella Health Inc., €372.
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
All filings by Margaret Koziel on record concern Axcella Health Inc., in the capacity of senior executive. Over a trading history stretching from 1 March 2022 to 1 March 2023, the count stands at 4 filings.
No open-market purchase appears, only 4 sales worth €3,796. So far in 2023, the count stands at no purchases and 1 sale.
Most recently, on 3 March 2023, the filings show an open-market sale worth €372 in Axcella Health Inc. The median gap between a trade and its publication by SEC (Form 4) is 2 days. For comparison, the SEC allows two business days to file a Form 4. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
4 of 4 declarations